David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depth David Endicott, Chief Executive Officer ...

David Endicott Thanks, Tim. In closing, I really want to thank our associates who have worked together tirelessly on behalf of our patients and customers. And our commitment to help people see ...

CEO David Endicott pointed to building momentum in the second half of 2025, with particular strength in equipment and ocular health. Endicott highlighted, "the launch [of Unity VCS] is delivering on ...

Alcon Inc. Chief Executive Officer David Endicott warned that the Trump administration’s push to link US drug prices to those ...

Alcon CEO David Endicott discusses the pharmaceutical firm's full-year results. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your ...

CEO David Endicott said, "Our second quarter results demonstrate the strength of our new products and the benefits of our innovation investments," and highlighted "7% sales growth" that was ...

Daniel Cravens: Welcome to Alcon's First Quarter 2026 Earnings Conference Call. Yesterday, we issued our press release, Interim financial report and earnings presentation. All of these documents are ...

NORTHRIDGE, Calif., June 29, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that David Endicott and Linnea Burman have joined its Board of ...

David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depth NORTHRIDGE, Calif., June 29, 2026 ...

David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience As MiniMed builds its next chapter as an independent company, Endicott adds ...